NANOBIOTIX (NANO.PA)
FR0011341205 - Common Stock
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -58.78M | -57.04M | -47.00M | -33.59M | -50.91M | |||
| Depreciation Amortization | 1.50M | 1.50M | 1.56M | 1.75M | 1.77M | |||
| Change In Working Capital | 4.06M | 2.30M | 11.54M | 5.76M | -1.52M | |||
| Interest Paid | 838.00K | 915.00K | 1.13M | 700.00K | 350.00K | |||
| Other non cash items | 16.37M | 16.14M | 4.03M | -1.47M | 9.50M | |||
| OPERATING CASH FLOW | -36.86M | -37.10M | -29.87M | -27.54M | -41.17M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -338.00K | -93.00K | -233.00K | -107.00K | -1.44M | |||
| Other Investing Activity | 96.00K | 231.00K | -9.00K | -5.00K | -15.00K | |||
| INVESTING CASH FLOW | -242.00K | 138.00K | -242.00K | -112.00K | -1.46M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -786.00K | -1.09M | -909.00K | 9.42M | 12.93M | |||
| Stock Issued/Repurchased | N/A | 0.00 | 0.00 | 113.65M | 29.52M | |||
| Other Financing Activity | -3.50M | -4.56M | -4.27M | -11.30M | -961.00K | |||
| FINANCING CASH FLOW | -4.28M | -5.65M | -5.18M | 111.77M | 41.49M | |||
| Exchange Rate Effect | -6.00K | 83.00K | 64.00K | -63.00K | 29.00K | |||
| CHANGE IN CASH | -41.39M | -42.53M | -35.23M | 84.06M | -1.11M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -36.86M | -37.10M | -29.87M | -27.54M | -41.17M | |||
| Capital Expenditure | -338.00K | -93.00K | -233.00K | -107.00K | -1.44M | |||
| FREE CASH FLOW | -37.20M | -37.20M | -30.11M | -27.64M | -42.61M | |||
All data in EUR